Document:

Patent License and Settlement Agreement dated June 27, 2006

 Exhibit 10.29 
 PATENT LICENSE AND SETTLEMENT AGREEMENT 
 This Patent License and Settlement Agreement
(“Agreement”), dated and effective as of June 28, 2006, is made and entered into in duplicate originals by and between PALM, INC. (“Palm”), a Delaware corporation having its principal office and place of business at 950 W.
Maude Ave., Sunnyvale, California 94085, and XEROX CORPORATION (“Xerox”), a New York corporation having its principal place of business at 800 Long Ridge Road, Stamford, Connecticut 06904, acting on behalf of itself and in the interest of
its Subsidiaries (individually identified as “Party” and collectively as “Parties”). In consideration of the mutual covenants and obligations herein undertaken, Xerox and Palm agree as follows: 
 Article 1. – Definitions  
 In this
Agreement, the following terms shall have the respective meanings set forth below: 
  

	1.1	 	“Effective Date” means the date set forth at the outset hereof. 

  

	1.2	 	 “Palm Licensed Field” means (i) mobile computing devices and/or communications devices, (ii) subsystems and modules of such devices,
(iii) the processes employed in the manufacture of such devices, (iv) materials, components, parts or accessories used in such devices, (v) any additional software or hardware products used to operate with, in and/or to support such
devices and (vi) services employing, utilizing, interfacing (directly or indirectly) with or relating to such devices. The Palm Licensed Field does not include mobile computing devices comprising a display having a diagonal dimension equal to
or 

  

 1 
 —CONFIDENTIAL 

	 	 
greater than eleven (11) inches but does include accessories to be used with devices included within the Palm Licensed Field regardless of screen size.

  

	1.3	 	“Xerox Licensed Field” means (i) non-mobile marking systems (i.e., photocopiers, scanners, facsimile machines, and printers) of any type, kind or configuration
and/or subsystems of such systems or the processes for making such systems or subsystems and (ii) materials, components, parts or accessories used in such devices including, but not limited to toner resins and components; ink vehicles and
components; photoreceptor components; photo imageable materials; pigment dispersants; printing media and components; printing devices and components; magnetic materials, components and media; display materials, components and materials; optical
materials and components; photographic materials and components; other imaging materials and device components; information storage and retrieval devices, materials and components; document security and authentication devices, materials and
components, and (iii) business solutions and services employing, utilizing or interfacing with such devices. For avoidance of doubt, Xerox Licensed Field shall not include mobile computing devices and/or mobile communication devices and items
set forth in Section 1.2., parts (ii), (iii), (iv), (v), (vi); specifically adapted for such devices. 

  

	1.4	 	“Licensed Field” means either the Palm Licensed Field or the Xerox Licensed Field. 

  

	1.5	 	 “Licensed Patents” means (i) United States Patent No. 5,596,656 (together with the Patent Family thereof, collectively, the
“Patent In Suit”), and (ii) United States Patent No. 5,408,250 and United States Patent No. 5,119,079, together with 

  

 2 
 —CONFIDENTIAL 

	 	 
the Patent Family of each such patent. 

  

	1.6	 	“Subsidiary or “Subsidiaries” means any company, affiliate, division, enterprise or other business unit or Entity owned or controlled either directly or
indirectly by an Entity: (i) through ownership or control of fifty percent (50%) or more of voting stock or other voting interest, provided, however, that in any country where such Entity is not permitted by law to own fifty percent
(50%) or more of the voting stock or other voting interest of a local company, then such local company shall be deemed a subsidiary for purposes of this Agreement if such Entity owns the maximum voting stock or other voting interest that a
foreign investor may own and if the business activities of the local company are substantially controlled by such Entity; or (ii) in the case of a joint venture company formed by such Entity and an independent, preexisting company, fifty
percent (50%) or more of voting stock or other voting interest that a foreign investor may own and if the business activities of the local company are substantially controlled by such Entity; or (iii) in the case of a joint venture company
formed by such Entity and an independent, preexisting company, fifty percent (50%) or more of the voting stock or other voting interest. 

  

	1.7	 	 “Released Parties” means (i) Palm and its Subsidiaries existing as of the Effective Date, and PalmSource, Inc., an entity formerly owned by
Palm, and its Subsidiaries, as well as (ii) the current and former employees, officers, directors, agents, and shareholders of any Entity (for the purpose of clarity, the release of Section 3.3 to PalmSource, Inc. and its shareholder
ACCESS Co., Ltd. shall operate to release ACCESS Co., Ltd. with respect to activities of PalmSource, Inc 

  

 3 
 —CONFIDENTIAL 

	 	 
to the extent that PalmSource, Inc. is released under the terms of this Agreement) set forth in subsection (i) above acting in such capacity,
(iii) the Covered Entities of any Entity set forth in subsection (i) above to the extent such Covered Entities’ liability arises from the Sale, offer for Sale, importation, or use of a product or service acquired from an Entity set
forth in subsections (i) or (ii) above, and (iv) the respective successors and assigns of each of the foregoing, whether direct or indirect, immediate or remote of any of them. Released Parties shall also, for purposes of
Section 3.3 of this Agreement, include (a) Other Defendants, (b) the employees, officers, directors, agents and shareholders of each of the Other Defendants acting in such capacity, (c) the Covered Entities of the Other
Defendants to the extent such Covered Entities’ liability arises from the Sale, offer for Sale, importation, or use of a product or service acquired from an Entity set forth in subsections (a) or (b) above, and (d) the respective
successors and assigns of each of the foregoing, whether direct or indirect, immediate or remote of any of them. 

  

	1.8	 	“Sell,” “Sale” and “Sold” mean to make, have made (as limited in Section 3.4 below), sell, offer for sale, lease or license,
offer under a license, offer, provide, or use as or in connection with providing a service, import, export, use, or permit the use, sale, offer for sale, lease, import or export of, or otherwise deal in, transfer or dispose of, or permit the
transfer or disposition of, a product or service by a Party, either directly to any Entity (including any Subsidiary), or directly or indirectly to the Party’s Covered Entities. 

  

	1.9	 	 “Term of this Agreement” means the period commencing on the Effective Date 

  

 4 
 —CONFIDENTIAL 

	 	 
of this Agreement and continuing until expiration of the last-to-expire Licensed Patent or the first day following the expiration of the Covenant Term as set
forth in Section 1.10, whichever shall last occur. 

  

	1.10	 	“Pending Action” means that certain action pending before the United States District Court for the Western District of New York, and styled and captioned: Xerox
Corporation v. 3Com Corporation, U.S. Robotics Corporation, U.S. Robotics Access Corp., Palm Computing, Inc., Palm Inc., PalmSource, Inc., and PalmOne, Inc. under Case No. 6:97 – CV-6182T and assigned to Judge Michael A. Telesca, and any
and all appeals resulting therefrom. 

  

	1.11	 	“Covenant Term” means a period starting upon the Effective Date and ending seven (7) years after the Effective Date. 

  

	1.12	 	 “Covenant Patents” means any Patents issued as of the Effective Date or at any time during the Covenant Term on a patent application filed, or
claiming priority from a patent application filed, prior to the Effective Date, which the covenanting Party or any of its current or future Subsidiaries (i) owns (whether solely or jointly with any other Entity) or controls, or (ii) has a
license or other right and has the ability to covenant not to sue the other Party, without an obligation to pay royalties or fees to any Third Party (provided however, that the other Party shall be entitled, at its election, to include such
Patent within the definition of “Covenant Patent” under subparagraph (ii) above if such Party pays to the covenanting Party all royalties and fees that the covenanting Party owes to such Third Party as a result of the grant of the
covenant hereunder with respect to such Patent). Notwithstanding the foregoing, in the event, under either subparagraphs 

  

 5 
 —CONFIDENTIAL 

	 	 
(i) or (ii) above, the covenanting Party cannot, without breaching or otherwise abrogating the terms of any agreement with a Third Party entered into
prior to the Effective Date of this Agreement, make such covenant as to any patent, such patent shall not be deemed a Covenant Patent under this Agreement. 

  

	1.13	 	“Covered Entities” means, with respect to any Entity, (i) the direct and indirect end-users, other customers (including, without limitation, OEMs and private
label customers), contractors, resellers, distributors (including through multiple tiers of distribution), sales representatives, dealers, independent service and/or repair centers, in each case, of such Entity, and (ii) with respect to goods
and services (other than liquid crystal displays) supplied to such Entity and which such Entity designed by itself or had others design for itself, the direct and indirect suppliers or manufacturers of such Entity to the extent that such direct and
indirect suppliers or manufacturers supply such goods and services to the Entity. 

  

	1.14	 	“Entity” means any person or entity, whether an individual, corporation, partnership, limited partnership, limited liability company, trust, foundation,
unincorporated organization, business association, firm, joint venture or other legal entity. 

  

	1.15	 	“Other Defendants” mean each and every party named as a defendant in the Pending Action and each of their respective Subsidiaries. 

  

	1.16	 	“Patents” means all classes or types of patents (including design and utility patents), utility models and industrial designs in all countries of the world, and
applications therefor, together with any substitutions, divisions, continuations, continuations-in-part, reissues and results of re-examinations thereof. 

  

 6 
 —CONFIDENTIAL 

	1.17	 	“Patent Family” means, with respect to a patent, collectively, all patents and patent applications that are substitutions, divisions, continuations,
continuations-in-part, reissues, reexaminations, extensions and counterparts thereof in all countries of the world, including, without limitation, any patent or patent application claiming priority from such patent, and any patent or patent
application from which any such patent claims priority. 

  

	1.18	 	“Patent In Suit” shall have the meaning set forth in Section 1.5. 

  

	1.19	 	“Suit” means any legal or equitable action, claim or demand in any court or before any tribunal or any arbitration or compulsory and binding alternative dispute
resolution proceeding. 

  

	1.20	 	“Third Party” means an Entity other than Xerox or Palm or their respective Subsidiaries. 

 Article 2. – Warranties And Representations  
  

	2.1	 	Xerox hereby makes the following warranties and representations to Palm: 

  

	 	(a)	 	Xerox has the right to grant rights, licenses, privileges, releases and immunities under or relating to the Licensed Patents and Covenant Patents of Xerox or any Subsidiary
including the rights, licenses, privileges, releases and immunities granted hereunder to Palm, its Subsidiaries, and the other Released Parties; 

  

	 	(b)	 	Xerox has all requisite corporate power and authority to enter into and deliver this Agreement on behalf of itself and its Subsidiaries and to carry out the provisions of this
Agreement and cause its Subsidiaries carry out the provisions of this Agreement; 

  

	 	(c)	 	 There are no liens, conveyances, mortgages, assignments, encumbrances or 

  

 7 
 —CONFIDENTIAL 

	 	 
other agreements which would prevent or impair the full and complete exercise of all substantive rights, licenses, privileges, releases and immunities
granted by Xerox or its Subsidiaries to Palm, its Subsidiaries, Released Parties and their respective Covered Entities pursuant to the terms and conditions of this Agreement; 

  

	 	(d)	 	As of the Effective Date, the Licensed Patents have not been held to be invalid or unenforceable in any court proceeding, other than the Patent In Suit in the Pending Action, and
there are no United States Patent and Trademark Office actions pending relating to the Licensed Patents; and 

  

	 	(e)	 	No royalty or other fee or remuneration arising under the Licensed Patents is or shall be due to any third party for the Sale of products by Palm or its Subsidiaries or their
respective Covered Entities or the manufacture or supply of products to Palm or its Subsidiaries or their respective Covered Entities as permitted under the terms of this Agreement. This paragraph shall not waive, restrict or otherwise limit the
payment due to Xerox under Article 4 hereof. 

  

	2.2	 	Palm hereby makes the following warranties and representations to Xerox: 

  

	 	(a)	 	Palm has the right to grant rights, privileges, releases and immunities granted hereunder under or relating to Covenant Patents of Palm or any Subsidiary including the rights,
privileges, releases and immunities granted hereunder to Xerox and its Subsidiaries; and 

  

	 	(b)	 	 Palm has all requisite corporate power and authority to enter into and deliver this Agreement on behalf of itself and its Subsidiaries and to carry out the
provisions of this Agreement and to cause its Subsidiaries to carry out the 

  

 8 
 —CONFIDENTIAL 

	 	 
provisions of this Agreement. 

  

	2.3	 	Each Party hereby represents and warrants to the other Party that: 

  

	 	(a)	 	The execution, delivery and performance by such Party have been approved by all requisite action on the part of such Party, and no other corporate proceeding on the part of such
Party is necessary to authorize this Agreement; 

  

	 	(b)	 	Such Party’s execution, delivery and performance of this Agreement do not and will not conflict with, violate or result in any breach of any relevant law or any provision of
any license, agreement, contract, understanding, arrangement, commitment or undertaking of any nature (whether written or oral) to which such Party is a party; and 

  

	 	(c)	 	Neither Party nor its Subsidiaries has assigned, sold, or otherwise transferred any legal claim that it has or may have against the other Party or its Subsidiaries to any third
party (including any Subsidiary) or otherwise structured its affairs in a manner so as to avoid the release of any such claims pursuant to Section 3.3 below or otherwise to limit or exclude Patents from the covenants granted under Article 5.

  

	Article 3. –	Dismissal of Lawsuit, Grant Of Licenses, Releases, Non-Assertions Under The Licensed Patents, And No Admission 

 In consideration of the Payments to be made by Palm to Xerox specified in Section 4.1 hereof, and for other good and valuable consideration:

  

	3.1	 	 Dismissal of Lawsuit. Within one (1) business day after receipt of the full Payment due under Section 4.1 by Palm, Xerox shall file with the United
States 

  

 9 
 —CONFIDENTIAL 

	 	 
District Court for the Western District of New York a signed copy of the Stipulation of Dismissal of Claims attached hereto as Exhibit A as to the defendants
in the Pending Action pursuant to FRCP 41(a)(1). This Agreement comprises a full and final settlement of all claims of past and future patent infringement with respect to the Patent In Suit, including, without limitation, those claims of patent
infringement originally brought against Palm or Palm’s predecessors in the Pending Action. By filing the Stipulation of Dismissal of Claims attached hereto as Exhibit A as to defendants in the Pending Action pursuant to FRCP 41(a)(1) with the
United States Court for the Western District of New York, Xerox shall dismiss the aforementioned claims of patent infringement with prejudice. 

  

	3.2	 	 Grant of Licenses. Xerox, on behalf of itself and its Subsidiaries, hereby grants to Palm and each of its Subsidiaries a non-exclusive, fully paid-up,
royalty-free, and irrevocable license, privilege and immunity under all claims of the Licensed Patents (with the right to sublicense to PalmSource, Inc., to each of the Subsidiaries of PalmSource, Inc., and to the Other Defendants, in each case,
with a right to grant further sublicenses to each of their respective direct and indirect end-users, other customers (including, without limitation, OEMs and private label customers), contractors, resellers, distributors (including through multiple
tiers of distribution), sales representatives, dealers, independent service and/or repair centers, in each case, of such Entity within the scope of the licenses granted to Palm herein (but with no right of such Covered Entities to sublicense
further), and otherwise as specifically provided in Article 10 and Section 13.3) to make, have 

  

 10 
 —CONFIDENTIAL 

	 	 
made, use, import, export, offer for Sale, Sell, lease and otherwise dispose of any product and service, and to practice any method, in the Palm Licensed
Field (and with respect to the Patent In Suit, any product or service, or the practice of any method, in any and all fields of use) anywhere in the world. The term of such license shall be from the Effective Date until the expiration of the
last-to-expire Licensed Patent. Upon the request of Palm, Xerox shall, without additional consideration or unreasonable delay, grant directly to PalmSource, Inc., Access Co., Ltd. to the extent necessary and limited to the operation of
PalmSource, Inc., and 3Com, a license under the Patent-In-Suit of the scope of the sublicense that Palm is authorized to grant to PalmSource and/or the Other Defendants, respectively, described in this Section 3.2. 

 

	3.3	 	 Releases. (a) Provided that Xerox has received the Payment due Xerox under Section 4.1 hereof, then, to the maximum extent permitted under
applicable law, as of the Effective Date, Xerox, on behalf of itself and its Subsidiaries, and for their respective successors and assigns, hereby irrevocably releases, acquits and forever discharges the Released Parties from any and all actions,
causes of action, claims or demands whatsoever, in law or equity, resulting from the direct or indirect infringement or alleged infringement (including inducement of infringement or contributory infringement), either past or future, of any claims of
the Licensed Patents which Xerox or any of its Subsidiaries had or may have had prior to the Effective Date under the Licensed Patents, which could be asserted against the Released Parties, including, without limitation, arising out of the
manufacture, having manufactured, use, Sale, offer for Sale, lease, import, export 

  

 11 
 —CONFIDENTIAL 

	 	 
or other disposition of any product or service, or the practice of any method, anywhere in the world in the Palm Licensed Field (and with respect to the
Patent In Suit, any activity, product or service whatsoever). 

  

	    	 	(b) Xerox, on behalf of itself and its Subsidiaries, hereby irrevocably and forever expressly waives all rights Xerox and/or its Subsidiaries may have arising under California Civil
Code Section 1542 and all similar rights under the laws of any other applicable jurisdictions with respect to the release granted by Xerox under Section 3.3. Xerox understands that Section 1542 provides that: 

A general release does not extend to claims which the creditor does not know or suspect to exist in his favor at the time of executing the release,
which if known by him must have materially affected his settlement with the debtor. 
  

	    	 	Xerox acknowledges that it has been fully informed by its counsel concerning the effect and import of this Agreement under California Civil Code Section 1542 and similar laws
of any other applicable jurisdictions. 

  

	3.4	 	Notwithstanding anything to the contrary in this Agreement, in the event that any Third Party designs by itself or has others design for itself any product and such Third Party
possesses the design authority thereof, and Palm or any of its Subsidiaries sells or otherwise transfer such product exclusively to such Third Party, or its parent, Subsidiary or affiliate, then the license and the covenants, including the
“have made” right or covenant, granted to such Party and its Subsidiaries in Section 3.2, 5.1 and 5.2 hereunder, as applicable, shall not extend to such product. 

  

 12 
 —CONFIDENTIAL 

	3.5	 	Nothing in this Agreement shall be construed to grant Palm any right: 

  

	 	(a)	 	to license any third party to Sell any products under the Licensed Patents except as expressly provided in Section 3.2; 

  

	 	(b)	 	under the Licensed Patents, other than as set forth herein; or 

  

	 	(c)	 	except as expressly provided in Sections 3.2, 13.3 and Article 10, to sublicense, transfer or assign, in whole or in part, any of its rights under this Agreement, whether by
operation of law, implication, estoppel or otherwise. 

  

	3.6	 	This Agreement is entered into in order to compromise and settle disputed claims and proceedings, and neither this Agreement, nor any payment, license, release, covenant not to sue
or other transaction undertaken pursuant thereto or hereto, constitutes or shall be construed at any time for any purpose as an admission of liability by Xerox, Palm, or any Released Party with respect to any claim or contention of infringement or
validity or enforceability of any Licensed Patent or Covenant Patent of Palm or Xerox or their respective Subsidiaries, and without any acquiescence on the part of either Party or the Released Parties, as to the merit of any claim, defense,
affirmative defense, counterclaim, liabilities or damages related to any Licensed Patents or Covenant Patents or the Pending Action. 

 Article 4. – Payment  
  

	4.1	 	 In full and final consideration for the rights, licenses, privileges, covenants, immunities and releases set forth in Article 3 hereof and the covenants not to
assert and sue set forth in Article 5 hereof, and in reliance upon Xerox’s 

  

 13 
 —CONFIDENTIAL 

	 	 
warranties and representations set forth in Article 2 hereof, and for other good and valuable consideration, Palm shall pay to Xerox the cumulative sum of
Twenty Two Million Five Hundred Thousand dollars ($22,500,000.00), (“Payment”). The Payment shall be made on or before the Effective Date. The Payment shall be comprised of a Settlement Payment in the amount of Twelve Million
dollars ($12,000,000.00) which the Parties agree and acknowledge relates to the Patent In Suit and releases related thereto, and a License and Covenant Payment in the sum of Ten Million Five Hundred Thousand dollars ($10,500,000.00) which the
Parties acknowledge and agree is related to the license of the Licensed Patents other than the Patents In Suit and the covenant not to sue and assert set forth in Article 5 of this Agreement. No portion of such sums due Xerox under this
Section 4.1 shall be refundable for any reason whatsoever absent a material breach of this Agreement by Xerox as determined by a court of competent jurisdiction. 

  

	4.2	 	The Payment provided for in Section 4.1 will be made by Palm to Xerox, by electronic transfer of funds, as follows: 

  

	
	 Name of Payee:

	
	
	 Address:

	
	 Bank:

	 ABA Number:

	 Bank Address:

	 Account Name:

	 Account Number:

	 SWIFT #:

  

	4.3	 	 There is no payment of any kind which is due or which would become due or is to 

  

 14 
 —CONFIDENTIAL 

	 	 
be made hereafter other than the Payment to Xerox pursuant to Section 4.1 hereof including, by way of example, and without limitation, to Xerox, or its
counsel, or its license agent, or anyone in privity with Xerox or its counsel, or its licensing agent, or any successor or assignee of any of the Licensed Patents. 

  

	4.4	 	Taxes: The Parties hereto agree that no deduction or withholding on account of any tax, duty, levy, excise or similar impost is required by law in respect of any payment due to
Xerox under this Agreement. If required by law to perfect exemption from tax the parties will undertake to use their best commercial efforts to execute and deliver such instruments, documents or assurances and take such other actions as shall be
legally required. 

 Article 5. – Covenants Not to Assert  
  

	5.1	 	 i. Xerox Covenant Not to Assert: Xerox and its Subsidiaries agree and covenant to Palm that Xerox and its Subsidiaries shall not (and shall not grant consent
to or otherwise assist, instruct, or encourage any Third Party to) bring, participate in, assist or allow any Suit against Palm, any of its Subsidiaries and their direct and indirect end-users, other customers (including, without limitation, OEMs
and private label customers), contractors, manufacturers as identified in Section 1.13, resellers, distributors (including through multiple tiers of distribution), sales representatives, dealers, independent service and/or repair centers, for
direct or indirect infringement (including inducement of infringement or contributory infringement) of any Covenant Patent of Xerox or its Subsidiaries, in each case, with respect to products or services that are made, used, provided, Sold, offered
for Sale, imported or otherwise acquired or disposed of by or for 

  

 15 
 —CONFIDENTIAL 

	 	 
Palm or any of its Subsidiaries (including, without limitation, products Sold or otherwise disposed of to or through Covered Entities of Palm or its
Subsidiaries) at any time prior to or during the Covenant Term and within the Palm Licensed Field. The obligations of Xerox and its Subsidiaries under the foregoing sentence shall become effective upon the Effective Date and shall remain in effect
during the Covenant Term and perpetually after the expiration or termination thereof for any reason. Nothing set forth in this Section shall in any way limit the right of Xerox or its Subsidiaries to assert against Palm or any of its Subsidiaries
any claim under the Covenant Patents arising from activities outside of the Palm Licensed Field or occurring after the end of the Covenant Term. 

  

	    	 	 ii. Xerox Covenant Not to Assert: Xerox and its Subsidiaries agree and covenant to Palm that Xerox and its Subsidiaries shall not (and shall not grant
consent to or otherwise assist, instruct, or encourage any Third Party to) bring, participate in, assist or allow any Suit against PalmSource and Access, any of their Subsidiaries and their direct and indirect end-users, other customers (including,
without limitation, OEMs and private label customers), contractors, manufacturers as identified in Section 1.13, resellers, distributors (including through multiple tiers of distribution), sales representatives, dealers, independent service
and/or repair centers, for direct or indirect infringement (including inducement of infringement or contributory infringement) of any Covenant Patent of Xerox or its Subsidiaries, in each case, with respect to products or services that are made,
used, provided, Sold, offered for Sale, imported or otherwise acquired or disposed of by or for PalmSource and Access or any of their Subsidiaries 

  

 16 
 —CONFIDENTIAL 

	 	 
(including, without limitation, products Sold or otherwise disposed of to or through Covered Entities of PalmSource and Access or its Subsidiaries) at any
time prior to January 1, 2007 and within the Palm Licensed Field. The obligations of Xerox and its Subsidiaries under the foregoing sentence shall terminate on January 1, 2007, and Xerox and its Subsidiaries shall have the right thereafter
to file suit to recover any damages arising prior to January 1, 2007. Furthermore, if requested in writing by Palm, prior to January 1, 2007, Xerox agrees to enter into negotiations with PalmSource to extend to PalmSource and Access a
covenant similar in nature to the covenants to Palm under Section 5.1. However, Xerox and its Subsidiaries shall be under no obligation to grant such covenant. 

  

	5.2	 	 Palm Covenant Not to Assert: Palm and its Subsidiaries agree and covenant to Xerox that Palm and its Subsidiaries shall not (and shall not grant consent to
or otherwise assist, instruct, or encourage any Third Party to) bring, participate in, assist or allow any Suit against Xerox, any of its Subsidiaries for direct or indirect infringement (including inducement of infringement or contributory
infringement) of any Covenant Patent, in each case, with respect to (1) products or services that are made, used, provided, Sold, offered for Sale, imported or otherwise acquired or disposed of by or for Xerox or any of its Subsidiaries
(including, without limitation, products sold or otherwise disposed of to or through Covered Entities of Xerox or its Subsidiaries) at any time prior to or during the Covenant Term and within the Xerox Licensed Field, and (2) the use by
employees or authorized contractors of Xerox or its Subsidiaries of hand-held mobile communications 

  

 17 
 —CONFIDENTIAL 

	 	 
devices that would fall within the Palm Licensed Field in connection with Xerox’s provision of installation or repair services relating to Xerox
products that fall within the Xerox Licensed Field. The obligations of Palm and its Subsidiaries under the foregoing sentence shall become effective upon the Effective Date and shall remain in effect during the Covenant Term and perpetually after
the expiration or termination thereof for any reason. Nothing set forth in this Section shall in any way limit the right of Palm or its Subsidiaries to assert against Xerox or any of its Subsidiaries any claim under the Covenant Patents arising from
activities outside of the Xerox Licensed Field or occurring after the end of the Covenant Term. 

  

	5.3	 	During the Covenant Period, in the event one party (“Asserting Party”) first files suit against the other party (“Defending Party”) for infringement of a patent
in the Defending Party’s Fields of Use, the application for which was filed after the Effective Date, such suit shall be brought in the US District Court in which the Defending Party resides (for Xerox in Stamford, Connecticut and for Palm in
San Jose California) and the Defending Party may assert by way of counterclaim against the Asserting Party, infringement of any patent, including but not limited to any patent that would otherwise be subject to the Covenant protections set forth in
this Article 5, including recovery of damages from the Effective Date. This clause shall not be interpreted to limit during or after the Covenant Period the Parties’ right to collect damages for Patents where the application was filed after the
Effective Date. 

 Article 6. Term 
  

 18 
 —CONFIDENTIAL 

	6.1	 	This Agreement shall become effective as of its Effective Date and shall remain in full force during the Term of this Agreement. 

  

	6.2	 	Surviving any expiration of this Agreement are (i) Sections 1, 2, and 6.2, (ii) Articles 3, 4, 5 (excluding Section 5.3), 7, 8, 9, 10, 11, 12, and 13; and
(iii) any cause of action or claim of Xerox or Palm, accrued or to accrue, because of any breach or default by the other party hereunder. 

 Article 7. – Disclaimer  
 Nothing in this Agreement is or shall be construed as: (i) a warranty or
representation by Xerox or any of its Subsidiaries as to the validity, scope or enforceability of the Licensed Patents; (ii) any warranty or representation by Xerox or any of its Subsidiaries that anything made, used, sold, licensed, offered
for sale, offered for license or otherwise disposed of under any license granted in this Agreement is or will be free from infringement of patents, copyrights, and other rights of unaffiliated third parties; (iii) an obligation on the part of
Xerox or its Subsidiaries to bring or prosecute actions or suits against third parties for infringement; or (iv) granting by implication, estoppel or otherwise any licenses under patents owned by Xerox or any of its Subsidiaries, including the
Licensed Patents, except as specifically defined in Section Article 3 of this Agreement. EXCEPT AS EXPRESSLY SET FORTH IN THIS AGREEMENT, NEITHER PARTY MAKES ANY REPRESENTATIONS OR EXTENDS ANY WARRANTIES OF ANY KIND, EITHER EXPRESS OR IMPLIED. THERE
ARE NO EXPRESS OR IMPLIED WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR THAT PRODUCTS OR THE USE OF PRODUCTS WILL NOT INFRINGE ANY PATENT, COPYRIGHT, 

  

 19 
 —CONFIDENTIAL 

 
TRADEMARK OR OTHER RIGHTS. Any warranty made by Palm or its Subsidiaries to their customers, users of the Products or any third parties are made by Palm or
its Subsidiaries alone and shall not bind Xerox or its Subsidiaries or be deemed or treated as having been made by Xerox or any of its Subsidiaries, and service of any such warranty shall be the sole responsibility of Palm and its Subsidiaries.

 Article 8. – Confidential Information 
  

	8.1	 	Each Party has disclosed certain proprietary technical or business information pursuant to a protective order (“Confidential Information”) during the course of the
Pending Action. Each Party agrees that such Confidential Information shall remain subject to applicable protective orders, and each Party will comply with the terms of each such protective order with respect to such Confidential Information. To the
extent still in their respective possession or control, each Party further agrees to return or destroy the Confidential Information of the disclosing Party, according to the terms of the Protective Order. 

  

	8.2	 	 Except for the right to disclose the existence of this Agreement and except for the rights of Xerox or Palm to disclose this Agreement pursuant to a protective
order entered in any infringement or other litigation involving the Licensed Patents and except as either party is required by law, regulation or other similar requirement to disclose, Xerox and Palm agree that neither Party will disclose any of the
terms of this Agreement to any person or entity other than to such Party’s attorneys, accountants, auditors, employees or agents (including any of the aforementioned of a Party’s Subsidiaries) having a need to know; or to third parties
under an obligation of confidence on terms substantially similar to those set forth herein 

  

 20 
 —CONFIDENTIAL 

	 	 
and then only for the good faith purpose of insuring the rights and obligations of the parties can be and are fully honored and protected; provided,
however, that Xerox and Palm may disclose the terms of this Agreement to the extent necessary to (1) comply with all applicable securities and tax laws, rules and regulations; (2) comply with an order of a court of competent
jurisdiction; or (3) disclose to customers, distributors, and dealers the fact that specific products of a Party are licensed or subject to a covenant not to sue as provided in this Agreement. Otherwise the Parties shall promptly notify the
other Party of any contest regarding the disclosure of this Agreement so that the other Party may act to prevent disclosure of this Agreement. The Parties shall agree to mutually approved press releases disclosing the settlement and dismissal of the
Pending Action. Notwithstanding the foregoing, either party may advise third parties that “Xerox has dismissed the [Pending Action] on mutually agreeable, confidential terms.” 

 Article 9. – Limitation of Liability  
  

	    	 	 NEITHER PARTY SHALL BE LIABLE TO THE OTHER PARTY OR ITS SUBSIDIARIES, THEIR SUPPLIERS, DISTRIBUTORS, CUSTOMERS, THE USERS OF ANY PRODUCT OF SUCH PARTY, OR ANY OTHER
THIRD PARTIES FOR INDIRECT, SPECIAL OR CONSEQUENTIAL DAMAGES, INCLUDING, WITHOUT LIMITATION, ANY DAMAGE OR INJURY TO BUSINESS EARNINGS, PROFITS OR GOODWILL SUFFERED BY ANY PERSON OR ENTITY ARISING FROM ANY USE OF THE LICENSED PATENTS OR COVENANT
PATENTS, EVEN IF SUCH PARTY IS ADVISED 

  

 21 
 —CONFIDENTIAL 

	 	 
OF THE POSSIBILITY OF SUCH DAMAGES. 

 Article 10. – Business Acquisition 
  

	    	 	In the event that a Party, subsequent to the Effective Date, acquires from a Third Party any ongoing business, Entity or product line, such acquired business, Entity or product line
(and, in each case, the making, using, Selling, offering for Sale and importing products and services thereof) shall automatically be deemed to be licensed under and otherwise entitled to the rights and immunities of such acquiring Party under this
Agreement (including, without limitation, Articles 3 and 5 hereof) retroactive to the date of such acquisition; provided, however, that in the event that the other Party (the “Litigating Party”) has filed a Suit against such
Third Party with respect to such ongoing business, Entity or product line prior to the date of the signing of a binding, definitive agreement with the acquiring Party with respect thereto, then the Litigating Party shall retain all such claims and
retains all rights to such Suit and any grant of licenses, rights and immunities of the acquiring Party with respect thereto shall be subject to such prior Suit. 

 Article 11. – Subsidiary Sale  
  

	    	 	 If any Subsidiary of a Party or any product line or business unit of a Party (the “Divesting Party”) is acquired during the Term of this Agreement,
the rights of the Divesting Party under this Agreement with respect to such Subsidiary, product line or business unit (as applicable) shall extend to the benefit of the acquirer and the acquirer shall automatically be deemed to have received a grant
from the other Party and its Subsidiaries of the rights, covenants and immunities under the 

  

 22 
 —CONFIDENTIAL 

	 	 
Licensed Patents and Covenant Patents of such other Party and its Subsidiaries with respect to such Subsidiary, product line or business unit (as
applicable), to the same extent that the Divesting Party would have been entitled to exercise its rights with respect to such Subsidiary, product line or business unit (as applicable) if such sale had not occurred. 

 Article 12. – Indemnity  
  

	12.1	 	Palm and its Subsidiaries agree to indemnify, hold harmless and defend Xerox, its affiliates and the holders of the Licensed Patents, their trustees, officers, directors, employees
and agents, against any and all claims for damages (including reasonable attorneys’ fees) arising out of the breach of any warranties made in Section 2.2, or based upon any breach by Palm this Agreement, except to the extent that such
liability arises out of any act or omission of Xerox. 

  

	12.2	 	The liability of Palm and its Subsidiaries under Section 12.1 is conditioned upon prompt notice by Xerox to Palm of all such claims after Xerox receives notice of their
existence and Xerox’s offering Palm an opportunity, to the extent permissible by applicable law, to assume their defense. In the event Palm assumes the defense of any such claim, Xerox (i) shall, at its expense, furnish Palm with any
information in Xerox’s possession or control that Palm reasonably may request for such defense, and (ii) reserves the right to continue to participate in the defense of its interests, at its own cost and expense. Palm shall not be liable
for any settlement or compromise unless, prior to any such agreement, Xerox notifies Palm of the proposed settlement or compromise and Palm approves such agreement, which approval shall not be unreasonably withheld. 

  

 23 
 —CONFIDENTIAL 

	12.3	 	Xerox agrees to indemnify, hold harmless and defend Palm and its Subsidiaries, their officers, directors, employees and agents, against any and all claims for damages (including
reasonable attorneys’ fees) arising out of the breach of any warranties made in Section 2.1 or any other breach by Xerox of this Agreement, except to the extent such liability arises out of any act or omission of Palm or its Subsidiaries.

  

	12.4	 	The liability of Xerox under Section 12.3 is conditioned upon prompt notice to Xerox by Palm or its Subsidiaries of all such claims after Palm or its Subsidiaries receive
notice of their existence and Palm or its Subsidiaries’ offering Xerox an opportunity, to the extent permissible by applicable law, to assume their defense. In the event Xerox assumes the defense of any such claim, Palm or its Subsidiaries
(i) shall, at their expense, furnish Xerox with any information in their possession or control that Xerox reasonably may request for such defense, and (ii) reserve the right to continue to participate in the defense of their interests, at
their own cost and expense. Xerox shall not be liable for any settlement or compromise unless, prior to any such agreement, Palm or its Subsidiaries notify Xerox of the proposed settlement or compromise and Xerox approves such agreement, which
approval shall not be unreasonably withheld. 

 Article 13. – Miscellaneous  
  

	13.1	 	 The rights and obligations of the Parties under this Agreement shall be governed by and construed in accordance with laws of the State of New York, without
reference to conflicts of laws principles. The Parties irrevocably submit to the exclusive jurisdiction of the federal and state courts of the State of Delaware; 

  

 24 
 —CONFIDENTIAL 

	 	 
provided, however, that each Party shall have the right to institute judicial proceedings against the other Party or anyone acting by, through or under such
other Party, in order to enforce the instituting Party’s rights hereunder through reformation of contract, specific performance, injunction or similar equitable relief. 

  

	13.2	 	The terms and conditions of this Agreement may only be amended by a writing signed by both Parties. 

  

	13.3	 	 Except as otherwise specifically provided in this Agreement, neither this Agreement nor any rights or obligations hereunder may be assigned, delegated or otherwise
transferred by Palm or Xerox, in whole or in part, whether voluntary or by operation of law, without the prior written consent of the other Party. Notwithstanding the foregoing, in the event that Palm is acquired by a Third Party (including, without
limitation, as a result of a sale of all or substantially all of the assets of a Party to a Third Party or a merger or consolidation), Palm and its Subsidiaries shall retain all rights hereunder (including, without limitation, under Articles 2 and 5
hereof) as long as either (1) the acquiring entity maintains Palm as a separate subsidiary, or (2) the acquiring entity merges Palm into the acquiring entity but maintains Palm as a separately-identifiable business, including where such
business is an unincorporated business unit or division of the acquiring entity. Notwithstanding the foregoing or anything to the contrary herein, in no event shall any such Third Party acquirer be bound by, or have any obligation under, the terms
and conditions of this Agreement (including, without limitation, under Article 5) with respect to any Patent other than (i) the Covenant Patents of 

  

 25 
 —CONFIDENTIAL 

	 	 
Palm and its Subsidiaries immediately prior to such acquisition, merger, consolidation or assignment, and (ii) the Patent Families thereof, to the
extent issuing within the Covenant Term. Subject to the foregoing, this Agreement will be binding upon, and inure to the benefit of, the Parties and their respective successor and assigns. In no event shall the Third Party’s products and
services existing prior to and/or as of the date of such acquisition be covered by this Agreement through the acquisition of Palm. 

  

	13.4	 	In the event of any sale, assignment, transfer, exclusive license, or other conveyance of any ownership interest in a Party’s Licensed Patents or Covenant Patents
(“Transfer”), such Party shall (i) ensure that the purchaser, assignee, transferee, or exclusive licensee (“Transferee”) shall, as a condition of such Transfer, be bound in writing by all applicable licenses,
immunities, covenants, and restrictions contained in this Agreement, and (ii) ensure that such Transfer does not affect such Party’s right and ability to perform all of its obligations under this Agreement. In no event shall such Party be
relieved or excused from any of its obligations under this Agreement as a result of such Transfer. Failure of a Party to satisfy this provision shall result in the Transfer to the Transferee becoming null and void. 

  

	13.5	 	 If a Subsidiary of a Party ceases to be a Subsidiary of such Party (“Change of Status”), the licenses, rights and immunities granted in this
Agreement under the Licensed Patents of such Subsidiaries will remain in effect, in accordance with the terms and conditions of this Agreement, with respect to such of those Licensed Patents and Covenant Patents that have an earliest filing date
prior to the 

  

 26 
 —CONFIDENTIAL 

	 	 
consummation of such Change of Status, but not with regard to any Patents that have an earliest filing date after the consummation of such Change of Status.

  

	13.6	 	Any notice required or permitted under this Agreement or required by law must be in writing and must be (i) delivered in person, (ii) sent by facsimile or electronic mail
with a hard copy of such facsimile sent by (international or domestic) registered or (international or domestic) express or, for domestic addresses, certified mail, postage prepaid, or 

	    	 	(iii) sent by overnight or next business day courier such as Federal Express, UPS or DHL, as follows: 

  

	 	    	 	If to Palm: 

  

	 	    	 	General Counsel 

	 	    	 	Palm, Inc. 

	 	    	 	950 W. Maude Avenue 

	 	    	 	Sunnyvale, CA 94085 

  

	 	    	 	If to Xerox: 

  

	 	    	 	General Patent Counsel 

	 	    	 	Xerox Corporation 

	 	    	 	800 Long Ridge Road 

	 	    	 	Stamford, Connecticut 06904 

  

	 	    	 	Copies to: 

  

	 	    	 	Associate General IP Counsel 

	 	    	 	Xerox Corporation 

	 	    	 	Xerox Square 20A 

	 	    	 	100 Clinton Avenue South 

	 	    	 	Rochester, New York 14644 

  

	    	 	 Either Party may amend its address by written notice to the other party in accordance with this Section. Notice may be given by counsel to the parties. Notices will
be deemed to have been given at the time of actual delivery in person 

  

 27 
 —CONFIDENTIAL 

	 	 
on a business day, five (5) business days (7 business days for international delivery) after deposit in the mail as set forth herein, or one
(1) business day after delivery to an overnight courier service (4 business days for international delivery). 

  

	13.7	 	Except as expressly provided herein, the rights and remedies herein provided shall be cumulative and not exclusive of any other rights or remedies provided by law or otherwise.
Failure by either Party to detect, protest, or remedy any breach of this Agreement shall not constitute a waiver or impairment of any such term or condition, or the right of such Party at any time to avail itself of such remedies as it may have for
any breach or breaches of such term or condition. A waiver may only occur pursuant to the express written permission of an authorized officer of the party against whom the waiver is asserted. 

  

	13.8	 	In the event any term, condition or provision of this Agreement is declared or found by a court of competent jurisdiction to be illegal, unenforceable or void, the Parties shall
endeavor in good faith to agree to amendments that will preserve, as far as possible, the intentions expressed in this Agreement. If the Parties fail to agree on such amendments, such invalid term, condition or provision shall be severed from the
remaining terms, conditions and provisions, which shall continue to be valid and enforceable to the fullest extent permitted by law. 

  

	13.9	 	This Agreement is the result of negotiations between Xerox and Palm and accordingly shall not be construed for or against a Party merely because such Party drafted this Agreement or
any portion thereof. 

  

	13.10	 	This Agreement is, and any amendment hereof, shall be written in English. 

  

 28 
 —CONFIDENTIAL 

	13.11	 	Titles of the Articles herein are for the convenience of reference only and shall not affect the construction of this Agreement. 

  

	13.12	 	Except as specifically provided in this Agreement, nothing contained herein shall be construed as a grant of, or as an intention or commitment to grant, to any party other than Palm
and its Subsidiaries any right, title or interest, of any nature whatsoever, in or to this Agreement or the license granted to Palm and its Subsidiaries hereunder. 

  

	13.13	 	This Agreement sets forth the entire agreement and understanding between the Parties and supersedes and cancels all previous negotiations, agreements and commitments, whether oral
or in writing, with respect to the subject matter described herein and therein, and neither Party shall be bound by any term, clause, provision, or condition save as expressly provided in this Agreement or as duly set forth in writing as a
subsequent amendment to this Agreement, signed by duly authorized officers of each Party, except that the Parties continue to be bound by the terms of the Protective Order previously issued in the Pending Action. Such Protective Order shall continue
in full force and effect and shall be deemed an agreement supplementary to this license for purposes of the Untied States Bankruptcy Code, 11 USC § 365(n). 

  

	13.14	 	This Agreement may be executed in two counterparts, each of which will be deemed an original and all of which together constitute one instrument. Executed counterparts of this
Agreement sent and received via facsimile or electronic transmission means shall be deemed originals for all purposes. 

  

	13.15	 	 All licenses granted to Palm under or pursuant to this Agreement are and shall be 

  

 29 
 —CONFIDENTIAL 

	 	 
deemed to be, for purpose of Section 365(n) of the U.S. Bankruptcy Code, licenses of rights to intellectual property as defined under Section 101
of the U.S. Bankruptcy Code, as amended. The Parties agree that Palm, as a licensee of such rights under this Agreement, shall retain and may fully exercise all of its rights and elections under the U.S. Bankruptcy Code, as amended.

  

	13.16	 	Each Party agrees (i) to furnish upon request to the other Party such further information, (ii) to execute and deliver to the other Party such other documents, and
(iii) to do such other acts and things, in each case as such Party may reasonably request for the purpose of carrying out the purposes, terms and conditions of this Agreement. 

  

 30 
 —CONFIDENTIAL 

 IN WITNESS WHEREOF, this Agreement has been duly executed by the Parties, as dated below, to be effective as of the
Effective Date. 
  

			
	 Palm, Inc.

		
	 By:
	 	 /s/ ANDREW J. BROWN

		 	 
		
	 Name:
	 	 Andrew J. Brown

		 	 
		
	 Title:
	 	 SVP Finance and CFO

		 	 
	
	 Xerox Corporation:

		
	 By:
	 	 /s/ SOPHIE V. VANDEBROEK

		 	 
		
		 	 Sophie V. Vandebroek

		
		 	 Vice President Chief
 Technology Officer and
 President Xerox
 Innovation Group

  

 31 
 —CONFIDENTIAL 

 EXHIBIT A 
 FORM OF STIPULATION OF DISMISSAL OF CLAIMS 
  

 32 
 —CONFIDENTIAL 

 IN THE UNITED STATES DISTRICT COURT FOR THE WESTERN DISTRICT OF NEW YORK 
  

					
	 XEROX CORPORATION,
	 	)	  	
			
		 	)	  	
			
	                                   Plaintiff,
	 	)	  	
			
		 	)	  	
			
	                     v.
	 	)	  	
			
		 	)	  	
			
	 3COM CORPORATION,
	 	)	  	 Civil Action No. 6:97-CV-06182

			
	 U.S. ROBOTICS CORPORATION,
	 	)	  	
			
	 U.S. ROBOTICS ACCESS CORP.,
	 	)	  	 Hon. Judge Michael A. Telesca

			
	 PALM COMPUTING, INC.,
	 	)	  	 Hon. Mag. Judge Jonathan W. Feldman

			
	 PALM, INC.,
	 	)	  	
			
	 PALMSOURCE, INC., and
	 	)	  	
			
	 PALMONE, INC.,
	 	)	  	
			
		 	)	  	
			
	                                   Defendants.
	 	)	  	
			
	  	 	)	  	

 STIPULATION OF DISMISSAL WITH PREJUDICE 
  
 The parties to the above-captioned civil action hereby agree and stipulate, pursuant
to a Confidential Settlement Agreement and the provisions of Fed. R. Civ. P. 41, that the above-captioned action is hereby dismissed with prejudice, with each party to bear its own costs and attorneys’ fees. 

							
	 Dated: June     , 2006
	 	 Respectfully submitted,

				
		 	 XEROX CORPORATION
	 		 	 3COM CORPORATION,

				
		 		 		 	 U.S. ROBOTICS CORPORATION,

				
		 		 		 	 U.S. ROBOTICS ACCESS CORP.,

				
		 		 		 	 PALM COMPUTING, INC.,

				
		 		 		 	 PALM, INC.,

				
		 		 		 	 PALMSOURCE, INC., and

				
		 		 		 	 PALMONE, INC.

				
	 By:
	 	  	 	 By:
	 	  
				
		 	 James A. Oliff
	 		 	 James L. Quarles III

				
		 	 Edward P. Walker
	 		 	 WILMER CUTLER PICKERING
HALE AND DORR LLP

				
		 	 Richard E. Rice
	 		 	 The Willard Office Building

				
		 	 Vu Q. Bui
	 		 	 1875 Pennsylvania Avenue, NW

				
		 	 OLIFF & BERRIDGE, PLC
	 		 	 Washington, DC 20006

				
		 	 277 South Washington Street
	 		 	 (202) 663-6000

				
		 	 Suite 500
	 		 	
				
		 	 Alexandria, Virginia 22314
	 		 	 William F. Lee

				
		 	 (703) 836-6400
	 		 	 WILMER CUTLER PICKERING
HALE AND DORR LLP

				
		 		 		 	 60 State Street

				
		 	 Donald R. Dunner
	 		 	 Boston, Massachusetts 02109

				
		 	 FINNEGAN, HENDERSON, FARABOW
GARRETT & DUNNER, L.L.P.
	 		 	 (617) 526-6000

				
		 	 901 New York Avenue, NW
	 		 	
				
		 	 Washington, DC 20001
	 		 	
				
		 	 (202) 408-4000
	 		 	 Joseph A. Regan

				
		 		 		 	 FARACI & LANGE

				
		 	 Harry P. Trueheart, III
	 		 	 2 State Street

				
		 	 Richard D. Rochford, Jr.
	 		 	 Crossroads Building

				
		 	 NIXON PEABODY LLP
	 		 	 Fourth Floor

				
		 	 1100 Clinton Square
	 		 	 Rochester, New York 14614

				
		 	 Rochester, New York 14604
	 		 	 (585) 325-5 150

				
		 	 (585) 263-1000
	 		 	
				
		 		 		 	 Attorneys for Defendants

				
		 	 Attorneys for PlaintiffSummary of May 10, 2006 oral agreement

 Exhibit 10.1 
 Summary of May 10, 2006 oral agreement with James A. Clishem, its President and Chief Executive Officer 
 On
May 10, 2006, Active Power entered into an oral agreement with James A. Clishem in connection with his appointment as Chief Executive Officer of the company. Pursuant to the terms of such agreement, Mr. Clishem will receive an annual base
salary of $300,000 and his annual bonus target under Active Power’s Executive Compensation Plan will be 100% of his annual base salary. Mr. Clishem also was granted, effective May 10, 2006, an option to purchase 200,000 shares of
Active Power common stock at an exercise price equal to the per-share fair market value on the date of grant, which shall vest at a rate of 25% per year over four years. Mr. Clishem will continue to participate in Active Power’s
employee benefit programs and will be entitled to a severance payment equal to six months of his then current salary in the event his employment is terminated by Active Power for reasons other than cause.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00107-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00107-of-00352.parquet"}]]